- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
GTx Inc+ Add to Watchlist
GTXI:US1.3400 USD 0.0100 0.75%
As of 20:10:00 ET on 07/11/2014.
Company Profile for GTx Inc (GTXI)
GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.
Key Executives for GTx Inc (GTXI)
|Marc S HanoverPresident/Interim CEO/COO||Henry P DoggrellVP/Chief Legal Officer/Secy|
|James T DaltonVP/Chief Scientific Officer||Jeffrey G HesselbergVP:Regulatory Affairs|
|Mary Ann JohnstonVP:Medical Affairs|